1Steimle AE, Stevenson LW, Chelimsky-Fallick C, et al. Sustained hemo- dynamic efficacy of therapy tailored to reduce filling pressures in survi- vors with advanced heart failure. Circulation, 1997,96 : 1165-1172.
2Hampton JR, van Veldhuisen D J, Kleber FX, et al. Randomized study of effect of ibopamine on survival in patients with advanced severe heart failure. Lancet, 1997,349:971-977.
3Anand IS, Florea VG, Fisher L. Surrogate end points in heart failure. J Am Coil Cardio1,2002,39 : 1414-1421.
4KG * 2Stevenson LW. Ciinical use of inotropic therapy for heart failure: Looking backward or forward.9 Part I:Inotropic infusions during hospi- talization. Circulation ,2003,108 : 367-380.
5Shipley JB, Tolman D, Hastillo A, et al. Review: milrinone : basic and clinical management. Am J Med Sei, 1996,311:286-291.
6Anderson JL for the United States Milrinone Multicenter Investigators. Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: Results of a Multicenter study in the United States. Am Heart J,1991,121:1956-1964.
7Yomani MH, Haji SA, Starling FC, et al. Comparison of dobutamine- based and milrinone-based therapy for advanced decompensated eonges- rive heart failure : Hemodynamic efficacy, clinical outcome, and economic impact. Am Heart J,2001,142:998-1002.
5Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416.
6Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442.
7Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fa/lure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005, 46: e1-e82.
8Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Aduks: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009, 119: 1977-2016.
9Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med, 2008, 36(1 Suppl) : S75-S88.
10Chen D, Assad-Kottner C, Orrego C, et al. Cytokines and acute heart failure. Crit Care Med, 2008, 36(1 Suppl) : S9-S16.
